Advertisement
ACHV vs MSLE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a StrongBuy and MSLE is a Hold.
ACHV in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 16, 2026
ACHV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 43 cases where ACHV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACHV's RSI Indicator exited the oversold zone, 19 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for ACHV just turned positive on October 28, 2026. Looking at past instances where ACHV's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
Following a +6.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHV advanced for three days, in 212 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 54 cases where ACHV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACHV as a result. In 64 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The 10-day moving average for ACHV crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for ACHV entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-47.118) is normal, around the industry mean (3.498). P/E Ratio (-4.048) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. ACHV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Momentum Indicator for MSLE turns positive, indicating new upward trend
MSLE saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned positive. In 80 of the 100 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MSLE's RSI Indicator exited the oversold zone, 13 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for MSLE just turned positive on October 27, 2026. Looking at past instances where MSLE's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Following a +17.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where MSLE advanced for three days, in 93 of 118 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 53 cases where MSLE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
The 50-day moving average for MSLE moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSLE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
MSLE broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MSLE entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. MSLE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.546) is normal, around the industry mean (3.498). P/E Ratio (-3.687) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MSLE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ACHV | MSLE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 46 | 34 | |
P/E GROWTH RATING 1..100 | 56 | 98 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACHV's Valuation (3) in the Biotechnology industry is in the same range as MSLE (35) in the null industry. This means that ACHV’s stock grew similarly to MSLE’s over the last 12 months.
ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MSLE (100) in the null industry. This means that ACHV’s stock grew similarly to MSLE’s over the last 12 months.
MSLE's SMR Rating (98) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that MSLE’s stock grew similarly to ACHV’s over the last 12 months.
MSLE's Price Growth Rating (34) in the null industry is in the same range as ACHV (46) in the Biotechnology industry. This means that MSLE’s stock grew similarly to ACHV’s over the last 12 months.
ACHV's P/E Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for MSLE (98) in the null industry. This means that ACHV’s stock grew somewhat faster than MSLE’s over the last 12 months.
| ACHV | MSLE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | 1 day ago 65% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 70% |
| Momentum ODDS (%) | 1 day ago 80% | 1 day ago 80% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 78% |
| Advances ODDS (%) | 3 days ago 80% | 3 days ago 79% |
| Declines ODDS (%) | 10 days ago 82% | 1 day ago 77% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACHV’s FA Score shows that 1 FA rating(s) are green while MSLE’s FA Score has 0 green FA rating(s).
- ACHV’s FA Score: 1 green, 4 red.
- MSLE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACHV’s TA Score shows that 4 TA indicator(s) are bullish while MSLE’s TA Score has 4 bullish TA indicator(s).
- ACHV’s TA Score: 4 bullish, 5 bearish.
- MSLE’s TA Score: 4 bullish, 5 bearish.
Price Growth
ACHV (@Biotechnology) experienced а +0.74% price change this week, while MSLE (@Biotechnology) price change was +11.30% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
ACHV is expected to report earnings on Mar 11, 2027.
MSLE is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ACHV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with BEAM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then BEAM could also see price increases.
| Ticker / NAME | Correlation To ACHV | 1D Price Change % | ||
|---|---|---|---|---|
| ACHV | 100% | N/A | ||
| BEAM - ACHV | 38% Loosely correlated | +2.62% | ||
| ABCL - ACHV | 36% Loosely correlated | -4.09% | ||
| OGEN - ACHV | 35% Loosely correlated | -0.58% | ||
| CRSP - ACHV | 34% Loosely correlated | +1.33% | ||
| ALLO - ACHV | 34% Loosely correlated | -3.41% | ||
More | ||||
MSLE and
Correlation & Price change
A.I.dvisor indicates that over the last year, MSLE has been loosely correlated with ANL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MSLE jumps, then ANL could also see price increases.
| Ticker / NAME | Correlation To MSLE | 1D Price Change % | ||
|---|---|---|---|---|
| MSLE | 100% | -4.80% | ||
| ANL - MSLE | 40% Loosely correlated | +8.94% | ||
| RVMD - MSLE | 33% Poorly correlated | -6.40% | ||
| BNTX - MSLE | 29% Poorly correlated | +0.50% | ||
| IPSC - MSLE | 27% Poorly correlated | +3.57% | ||
| ACHV - MSLE | 26% Poorly correlated | N/A | ||
More | ||||